APA (7th ed.) Citation

JL, W., QH, W., J, Y., HJ, B., XC, H., JC, C., . . . S, C. (2026). piR-26681 suppresses ovarian cancer progression by enhancing METTL3/METTL14-mediated m6A modification of FBXO16 and impairing DNA repair via MORF4L1 degradation. Cellular & molecular biology letters. https://doi.org/10.1186/s11658-026-00969-x

Chicago Style (17th ed.) Citation

JL, Wang, Wu QH, Yuan J, Bao HJ, Huang XC, Cheng JC, Zhao Y, and Chen S. "PiR-26681 Suppresses Ovarian Cancer Progression by Enhancing METTL3/METTL14-mediated M6A Modification of FBXO16 and Impairing DNA Repair via MORF4L1 Degradation." Cellular & Molecular Biology Letters 2026. https://doi.org/10.1186/s11658-026-00969-x.

MLA (9th ed.) Citation

JL, Wang, et al. "PiR-26681 Suppresses Ovarian Cancer Progression by Enhancing METTL3/METTL14-mediated M6A Modification of FBXO16 and Impairing DNA Repair via MORF4L1 Degradation." Cellular & Molecular Biology Letters, 2026, https://doi.org/10.1186/s11658-026-00969-x.